- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
August 8, 2013 (Newswise) ? An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
Patients who benefited most were those who still had relatively good control
July 8, 2013 (Colorado School of Public Health) ? Type 1 diabetes mellitus (T1DM) is increasing worldwide, with the most rapid increase among children younger than 5 years of age. Perinatal factors, such as birth delivery type, birth weight, infant growth, neonatal jaundice, and maternal age have been associated with T1DM and islet autoimmunity (IA), the preclinical stage of T1DM.
The purpose of the
June 30, 2013 (Newswise) ? In one of the few studies to provide information on eye screening of children, African-American children with the greatest risk for disease of the retina as a complication of Type 1 diabetes are the least likely to have received an eye exam, reports a team of resear
July 1, 2013 (Newswise) ? Respiratory infections in early childhood may be a potential risk factor for developing type 1 diabetes mellitus (T1D), according to a study published by JAMA Pediatrics, a JAMA Network publication.
The incidence of T1D is increasing worldwide, although its etiology is not well underst
May 29, 2013 (Newswise) ? Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.